{
    "organizations": [],
    "uuid": "c69a30c470e8489be75a903fb9c5a080e8e8066a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-novo-nordisk-ceo-new-ozempic-drug/brief-novo-nordisk-ceo-new-ozempic-drug-to-reach-at-least-dkk-1-billion-sales-in-2018-idUSC7N1JW02A",
    "ord_in_thread": 0,
    "title": "BRIEF-Novo Nordisk CEO: New Ozempic Drug To Reach At Least DKK 1 Billion Sales In 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2, 2018 / 6:48 AM / in 11 minutes BRIEF-Novo Nordisk CEO: New Ozempic Drug To Reach At Least DKK 1 Billion Sales In 2018 Reuters Staff 1 Min Read\nMay 2 (Reuters) - NOVO NORDISK A/S CEO LARS FRUERGAARD JORGENSEN SAID AT CALL AFTER Q1 EARNINGS:\n* SALES OF OZEMPIC DIABETES DRUG IS EXPECTED TO REACH AT LEAST DKK 1 BILLION IN 2018\n* VICTOZA DIABETES DRUG STILL LOSING MARKET SHARE TO ELI LILLYâ€™S TRULICITY, ALBEIT AT LOWER PACE FURTHER COMPANY COVERAGE: (Reporting by Stine Jacobsen)",
    "published": "2018-05-02T09:46:00.000+03:00",
    "crawled": "2018-05-02T10:06:53.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "minute",
        "nordisk",
        "ceo",
        "new",
        "ozempic",
        "drug",
        "reach",
        "least",
        "dkk",
        "billion",
        "sale",
        "reuters",
        "staff",
        "min",
        "read",
        "may",
        "reuters",
        "novo",
        "nordisk",
        "ceo",
        "lars",
        "fruergaard",
        "jorgensen",
        "said",
        "call",
        "q1",
        "earnings",
        "sale",
        "ozempic",
        "diabetes",
        "drug",
        "expected",
        "reach",
        "least",
        "dkk",
        "billion",
        "victoza",
        "diabetes",
        "drug",
        "still",
        "losing",
        "market",
        "share",
        "eli",
        "lilly",
        "trulicity",
        "albeit",
        "lower",
        "pace",
        "company",
        "coverage",
        "reporting",
        "stine",
        "jacobsen"
    ]
}